Skip to content
The Nexus
DossierENTITY

BioVAT

Coverage of BioVAT in the Nexus archive.

Earliest in view: May 27 · 21:00 UTCMost recent: May 27 · 21:00 UTC
Co-mentioned in this coverage
induced pluripotent stem cellstopic1left ventricular assist devicetopic1heart transplanttopic1heart failuretopic1STAT+organization1heart attacktopic1
Recent coverage
  • HEALTHMay 27 · 21:00 UTCSTAT NEWS
    STAT+: Heart patch engineered from stem cells revved up weakened hearts

    A small study reports that heart patches engineered from induced pluripotent stem cells (BioVAT) improved heart wall thickness and pumping ability in patients with weakened hearts. The patches aim to serve as a bridge to heart transplant or LVAD implantation, with a larger trial needed to assess durability and candidacy.